This year’s event will focus on 4 key themes: best practices for toxicological assessment, innovations in facility design automation, effective containment and cross-contamination prevention, and industry approaches to cleaning validation. Key case studies will be highlighted throughout these themes, revealing the key challenges for current HPAPI manufacture, and insights into the latest technological and regulatory advances in this increasingly potent environment. I will draw some parallels with what we are seeing in the COVID-19 crisis versus controlling exposure to API in Pharma.
